Reilly Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Reilly Financial Advisors's IBB Position: Q4 2021 in Review
Reilly Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q4 2021 at 516 shares worth $79K. The position accounts for 0.01% of the portfolio, ranked #324.
Reilly Financial Advisors first reported a position in IBB in Q1 2014 and has held it in 31 quarters since. The position peaked at $85K in Q2 2021. 963 funds tracked by Wall St. Rank hold IBB as of Q4 2021.
- Reilly Financial Advisors held 516 shares of iShares Biotechnology ETF worth $79K as of Q4 2021.
- Reilly Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q4 2021.
- iShares Biotechnology ETF made up 0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #324 holding.
- Reilly Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 31 quarters since.
- Reilly Financial Advisors's iShares Biotechnology ETF position peaked at $85K in Q2 2021.
- 963 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.